Pharmacological SERCA activation limits diet-induced steatohepatitis and restores liver metabolic function in mice
Journal of Lipid Research · 2024
DOI: 10.1016/j.jlr.2024.100558 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Lipid Research, 2024. Verfasst von Tomasz K Bednarski und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA. Hauptthemen laut MEDLINE: Sarcoplasmic Reticulum Calcium-Transporting ATPases, Liver. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease is the most common form of liver disease and poses significant health risks to patients who progress to metabolic dysfunction-associated steatohepatitis. Fatty acid overload alters endoplasmic reticulum (ER) calcium stores and induces mitochondrial oxidative stress in hepatocytes, leading to hepatocellular inflammation and apoptosis. Obese mice have impaired liver sarco/ER Ca2+-ATPase (SERCA) function, which normally maintains intracellular calcium homeostasis by transporting Ca2+ ions from the cytoplasm to the ER. We hypothesized that restoration of SERCA activity would improve diet-induced steatohepatitis in mice by limiting ER stress and mitochondrial dysfunction. WT and melanocortin-4 receptor KO (Mc4r-/-) mice were placed on either chow or Western diet (WD) for 8 weeks. Half of the WD-fed mice were administered CDN1163 to activate SERCA, which reduced liver fibrosis and inflammation. SERCA activation also restored glucose tolerance and insulin sensitivity, improved histological markers of metabolic dysfunction-associated steatohepatitis, increased expression of antioxidant enzymes, and decreased expression of oxidative stress and ER stress genes. CDN1163 decreased hepatic citric acid cycle flux and liver pyruvate cycling, enhanced expression of mitochondrial respiratory genes, and shifted hepatocellular [NADH]/[NAD+] and [NADPH]/[NADP+] ratios to a less oxidized state, which was associated with elevated PUFA content of liver lipids. In sum, the data demonstrate that pharmacological SERCA activation limits metabolic dysfunction-associated steatotic liver disease progression and prevents metabolic dysfunction induced by WD feeding in mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA.
- Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA.
- Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA; Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA. Electronic address: j.d.young…
Förderung
- NIDDK NIH HHS
- NIH HHS
- NCI NIH HHS
- National Cancer Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
- NIH Office of the Director
Zitieren
APA
Bednarski, T. K., Rahim, M., Hasenour, C. M., Banerjee, D. R., Trenary, I. A., Wasserman, D. H., & Young, J. D. (2024). Pharmacological SERCA activation limits diet-induced steatohepatitis and restores liver metabolic function in mice. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2024.100558
Vancouver
Bednarski TK, Rahim M, Hasenour CM, Banerjee DR, Trenary IA, Wasserman DH, et al. Pharmacological SERCA activation limits diet-induced steatohepatitis and restores liver metabolic function in mice. Journal of Lipid Research. 2024. doi:10.1016/j.jlr.2024.100558
BibTeX
@article{Bednarski2024,
author = {Bednarski, Tomasz K and Rahim, Mohsin and Hasenour, Clinton M and Banerjee, Deveena R and Trenary, Irina A and Wasserman, David H and Young, Jamey D},
title = {Pharmacological SERCA activation limits diet-induced steatohepatitis and restores liver metabolic function in mice},
journal = {Journal of Lipid Research},
year = {2024},
doi = {10.1016/j.jlr.2024.100558}
}
EUVIMED